Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less titan 1,750 grams

American Journal of Epidemiology

Volumn 152, Issue 2, 2000, Pages 120-124

  Boyle, C A ^a   Yeargin Allsopp, M ^a   Schendel, D E ^a   Holmgreen, P ^a   Oakley, G P ^b  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Cerebral palsy; Infant, low birth weight; Magnesium

Indexed keywords

CORTICOSTEROID; MAGNESIUM SULFATE;

ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; RISK;

ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; CEREBRAL PALSY; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK FACTORS; TOCOLYTIC AGENTS;

EID: 0034661886     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/152.2.120     Document Type: Article

References (15)

1. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants? Pediatrics 1995;95:263-9.
2. Schendel DE, Berg CJ, Yeargin-Allsopp M, et al. Prenatal exposure to magnesium sulfate and the risk of cerebral palsy or mental retardation among very low birth weight children aged 3 to 5 years. JAMA 1996;276:1805-10.
3. Paneth N, Jetton J, Pinto-Martin J, et al. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group. Pediatrics 1997;99:E1. (URL: http://www. pediatrics.org/cgi/content/full/99/5/e1).
4. O'Shea TM, Klinepeter KL, Dillard RG. Prenatal events and the risk of cerebral palsy in very low birth weight infants. Am J Epidemiol 1998;147:362-9.
5. Wilson-Costello D, Borawski E, Friedman H, et al. Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. Pediatrics 1998;102: 315-22.
6. Blair E, Palmer L. Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulfate. (Letter). Pediatrics 1996;97:780-2.
7. Allred EN, Dammann O, Kuban KK, et al. Prenatal magnesium sulfate exposure and risk of cerebral palsy. (Letter). JAMA 1997;277:1003.
8. American College of Obstetrics and Gynecology. Management of preeclampsia. (ACOG technical bulletin no. 91). Washington, DC: American College of Obstetrics and Gynecology, 1986.
9. American College of Obstetrics and Gynecology. Preterm labor. (ACOG technical bulletin no. 133). Washington, DC: American College of Obstetrics and Gynecology, 1989.
10. Murphy DJ, Sellers S, Mackenzie IZ, et al. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995;346:1449-54.
11. O'Shea TM, Klinepeter KL, Meis PJ, et al. Intrauterine infection and the risk of cerebral palsy in very low-birth weight infants. Paediatr Perinat Epidemiol 1998;12:72-83.
12. Boyle CA, Yeargin-Allsopp M, Doernberg NS, et al. Prevalence of selected developmental disabilities in children 3-10 years of age: The Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991. MMWR CDC Surveill Summ 1996;45:1-14.
13. Pinto-Martin JA, Riolo S, Cnaan A, et al. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics 1995;95: 249-54.
14. Shah BV, Barnwell BG, Bieler GS. SUDAAN: software for the statistical analysis of correlated data. User's manual, release 7.0. Research Triangle Park, NC: Research Triangle Institute, 1996.
15. Cooke RW. Trends in incidence of cranial ultrasound lesions and cerebral palsy in very low birthweight infants 1982-93. Arch Dis Child Fetal Neonatal Ed 1999;80:115F-17F.